What to do in marine biotechnology?

Tramper, J.; Battershill, Chris; Brandenburg, W.A.; Burgess, Grant; Hill, Russell T.; Luiten, Esther E.M.; Müller, Werner; Osinga, Ronald; Rorrer, Gregory L.; Tredici, Mario R.; Uriz, María Jesús; Wright, Phillip C.; Wijffels, René H.

doi:10.1016/s1389-0344(03)00077-7

Cited by 32 publications

(12 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This could be of great importance for the production of hydrogen, for example. However, a successful drug discovery is the most promising aspect of microalgal biotechnology because the potential is immense although screening remains limited (75).…”

Section: Resultsmentioning

confidence: 99%

Commercial applications of microalgae

Spolaore¹,

Joannis-Cassan²,

Duran³

et al. 2006

Journal of Bioscience and Bioengineering

3,649

2,010

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Commercial applications of microalgae

Spolaore¹,

Joannis-Cassan²,

Duran³

et al. 2006

Journal of Bioscience and Bioengineering

3,649

2,010

View full text Add to dashboard Cite

“…As presented in this review, some of the metabolites offer anti‐inflammatory, antimicrobial, antiviral, and antitumoral activities. However, many others exist that should be comprehensively screened in extended biomedical research programs, because successful drug discovery is one of the most promising aspects of microalgal biotechnology 185…”

Section: Introductionmentioning

confidence: 99%

Microalgae as sources of high added‐value compounds—a brief review of recent work

Guedes

Amaro²,

Malcata

2011

Biotechnology Progress

285

128

View full text Add to dashboard Cite

Microalgae have found commercial applications as natural sources of valuable macromolecules, including carotenoids, long-chain polyunsaturated fatty acids, and phycocolloids. As photoautotrophs, their simple growth requirements make them attractive for bioprocesses aimed at producing high added-value compounds that are in large demand by the pharmaceutical market. A few compounds synthesized by microalgae have indeed proven to possess anti-inflammatory, antiviral, antimicrobial, and antitumoral features; astaxanthin, a known antioxidant produced by Haematococcus pluvialis, is an illustrative example with important anti-inflammatory and antitumoral roles. From a chemical standpoint, several such compounds are polysaccharides or long chain fatty acids, where the latter can be either saturated or unsaturated. Additionally, their chemical structures are often atypical, whereas their concentrations can exceed those found in many other natural sources. The productivity and biochemical composition of microalgae depend strongly on the mode of cultivation, medium composition, and nutrient profile. Consequently, numerous efforts aimed at elucidating the practical impacts of the aforementioned parameters have been developed. This review accordingly covers the knowledge produced in the last two decades on the uses of microalgae to obtain physiologically active compounds, and on the optimization of the underlying production and purification processes. It also identifies major gaps and opportunities in this field that should be addressed or exploited in the near future.

show abstract

“…Both Omani and overseas researchers believe that greater scientific collaboration will contribute positively to their research productivity. Conferences provide useful platforms and have been used effectively in marine biotechnology to identify critical issues and solicit new ideas from experience delegates (Tramper et al 2003). In general, the issues which were raised during and following this symposium are similar to those which have been identified elsewhere by regional organizations (Marine Board-European Science 2010).…”

Section: Results and Conclusionmentioning

confidence: 93%

The First GCC Marine Biotechnology Symposium: Emerging Opportunities and Future Perspectives

et al. 2015

View full text Add to dashboard Cite

With its diverse, living marine resources and rapidly growing educational and research infrastructure, the Sultanate of Oman is well-positioned to take advantage of the commercial opportunities presented by marine biotechnology. In recognition of potential development, an international symposium, Marine Biotechnology-Emerging Opportunities and Future Perspectives, was held in Muscat, November 12-13, 2013. Three keynote addresses were given, 23 oral presentations made, and a poster exhibition held. The final session reviewed national and regional issues, and the delegates agreed informally on a number of future actions. The potential for future development of marine biotechnology was recognized by all delegates, and following the symposium, they were surveyed for their views on how best to sustain and develop new activities. One hundred percent of respondents found the meeting useful and would support future symposia in the region. Fifty-one percent of Omani respondents recognized major organizational challenges and obstacles to the development of marine biotechnology compared with 23 % of overseas respondents. The need for greater collaboration between research institutions within the GCC region was recognized by 98 % of all respondents. The presentations and survey outcomes are reviewed in this paper.

show abstract

What to do in marine biotechnology?

Cited by 32 publications

References 0 publications

Commercial applications of microalgae

Commercial applications of microalgae

Microalgae as sources of high added‐value compounds—a brief review of recent work

The First GCC Marine Biotechnology Symposium: Emerging Opportunities and Future Perspectives

Contact Info

Product

Resources

About